News
A wearable technology developed by Technion Professor Hossam Haick and colleagues in China enables real-time, noninvasive ...
2d
News-Medical.Net on MSNMapping metformin’s kidney effects through spatial multi-omics
Metformin is a widely used first-line therapy for type 2 diabetes, and studies increasingly point to its protective effects ...
Metformin is a widely used first-line therapy for type 2 diabetes, and studies increasingly point to its protective effects on the kidney. However ...
Learn how metformin may enhance cognitive function in schizophrenia by regulating energy metabolism and brain connectivity.
GLP-1 receptor agonists, a class of drug used to treat type 2 diabetes, likely trump the widely prescribed metformin for curbing dementia risk in people with the condition, finds the largest study of ...
This study for the first time to integrate spatial metabolomics and proteomics to decode metformin’s effects in diabetic kidney disease. By mapping ...
On Thursday, the giant health care conglomerate announced that it had “proactively reached out” to the Justice Department, ...
21h
Money Talks News on MSNThe Affordable Wonder Drug That Could Change Cancer Treatment
Metformin, already prescribed to millions worldwide for diabetes, may have hidden cancer-fighting properties. Watch the red sculpture of Trump emerge from a NYC manhole ...
9h
Medpage Today on MSNCardiovascular Risks Resurface Old Concerns About Sulfonylureas for T2D
Sulfonylureas as a whole are already known for their weight gain and hypoglycemia side effects. In practice, glipizide has ...
1d
HealthDay on MSNGLP-1 Receptor Agonists Tied to Decrease in T2DM-Related Dementia Risk
Glucagon-like peptide 1 receptor agonists (GLP-1 RAs) are associated with reduced type 2 diabetes mellitus (T2DM)-related ...
“This is the first major study to compare the effect of two common diabetes treatments — GLP-1 medicines and metformin — on dementia risk, using health records from more than 174,000 people. The ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results